PharmaVentures

PharmaVentures is a premier transaction advisory firm and a leading international company in M&A and licensing deals, valuations, market access and strategic advice. For over 30 years, PharmaVentures has acted as advisor on over 1,000 deal related assignments covering licensing, mergers, acquisitions, divestments, and joint venture activities for companies worldwide. PharmaVentures’ deep bank of specialist experience, deal analytics and network of contacts among innovators and large pharma makes it uniquely placed to support business in all aspects of strategic planning, deal making and commercial due diligence. PharmaVentures is well known for its deep insight into deal structures and its success for generating interest from both buyers and sellers leading to positive outcomes for its clients. PharmaVentures’ services include: • M&A (divestments, mergers, acquisitions, and strategic transactions) • Licensing (in and out licensing) • Fundraising Support • Strategy (commercialisation, deal strategy, due diligence, market entry) • Valuations (licensing, M&A, and fundraising) • Pricing and Market Access PharmaVentures Capital Ltd is a wholly owned subsidiary of PharmaVentures Ltd. All regulated activities are delivered through PharmaVentures Capital Ltd, which is authorised and regulated by the Financial Conduct Authority (741356). For more details, visit https://www.pharmaventures.com